Groin Complications Post Percutaneous Coronary Intervention Using Either Manual Compression or PERCLOSE Device
NCT ID: NCT00842179
Last Updated: 2009-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2517 participants
OBSERVATIONAL
2008-06-30
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial
NCT02237430
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose
NCT00507013
Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease
NCT04745624
The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
NCT02438475
Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients
NCT04689451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Manual Closure
Patients who received vascular closure with manual compression after percutaneous coronary intervention (PCI)
No interventions assigned to this group
Perclose Device
Patients who received vascular closure with the Perclose VCD after percutaneous coronary intervention (PCI)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received vascular closure by manual compression at Tampa General Hospital
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Clinyx, LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clinyx
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Roberts, MD
Role: PRINCIPAL_INVESTIGATOR
Baptist Health South Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baptist Hospital of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.